Management of Iron Deficiency Anemia from Blood Loss
Start with oral iron supplementation as first-line therapy, adding vitamin C to enhance absorption, and switch to intravenous iron if oral therapy fails, is not tolerated, or when rapid repletion is needed due to ongoing blood loss. 1
Initial Treatment Approach
Oral Iron Therapy (First-Line)
- Standard dosing: Oral iron remains the standard first-line treatment for most patients with iron deficiency anemia from blood loss 2
- Add vitamin C: Supplement oral iron with vitamin C to improve iron absorption 1
- Alternate-day dosing: Consider every-other-day dosing rather than daily, as this may be better tolerated with similar absorption rates 1
When to Switch to Intravenous Iron
Use IV iron in these specific situations 1:
- Intolerance: Patient cannot tolerate oral iron (GI side effects)
- Treatment failure: Ferritin levels do not improve after an adequate trial of oral iron
- Malabsorption: Conditions where oral iron absorption is compromised
- Ongoing blood loss: When GI blood loss exceeds intestinal iron absorption capacity (e.g., angiodysplasia) 3
IV Iron Administration
- Preferred formulations: Use IV iron preparations that replace iron deficits with 1-2 infusions rather than multiple infusions 1
- Safety profile: All IV iron formulations have similar risks; true anaphylaxis is very rare. Most reactions are complement activation-related pseudo-allergy (infusion reactions), not true allergic reactions 1
Identify and Address the Source of Blood Loss
Gastrointestinal Evaluation
For blood loss anemia, investigate both upper and lower GI tract to identify treatable causes 2:
- Consider bidirectional endoscopy in most cases
- Evaluate for common sources: peptic ulcer disease, angiodysplasia, malignancy, inflammatory bowel disease
- Test for Helicobacter pylori and celiac disease 4
Specific GI Bleeding Scenarios
Portal hypertensive gastropathy 1:
- Start with oral iron initially
- Switch to IV iron if ongoing bleeding and no response to oral therapy
- Consider nonselective β-blockers to treat portal hypertension if no other bleeding source identified
Gastric antral vascular ectasia (GAVE) 1:
- If inadequate response to iron replacement, proceed to endoscopic therapy
- Options: endoscopic band ligation or thermal methods (argon plasma coagulation)
Small bowel angioectasias 1:
- Perform deep enteroscopy with distal attachment for better detection
- Treat with ablative thermal therapies (argon plasma coagulation) or hemostatic clips
- Always accompany endoscopic treatment with iron replacement
- Reserve medical therapy for refractory cases when iron replacement and endoscopy fail
Special Populations
Inflammatory Bowel Disease
- Determine if IDA is from inadequate intake/absorption versus blood loss 1
- Treat active inflammation first to enhance iron absorption or reduce depletion
- Use IV iron in patients with active inflammation and compromised absorption 1
Post-Bariatric Surgery
- Use IV iron therapy in patients with procedures disrupting duodenal iron absorption who have IDA without identifiable chronic GI blood loss 1
Celiac Disease
- Ensure adherence to gluten-free diet to improve iron absorption 1
- Try oral iron supplementation based on severity and tolerance
- Use IV iron if stores don't improve 1
Monitoring and Treatment Targets
- Check ferritin levels to assess response to therapy
- Continue iron replacement until stores are replenished (ferritin >30-45 μg/L in most cases) 2
- In inflammatory conditions, ferritin <45 μg/L warrants consideration of continued therapy even if inflammation is present 2
Critical Pitfalls to Avoid
- Don't rely solely on hemoglobin: Iron deficiency can exist without anemia, particularly in menstruating women with flawed sex-specific reference ranges 4
- Don't use blood transfusion as iron replacement: Transfusion doesn't provide adequate elemental iron and should only be used for cardiovascular compromise, active bleeding, or severe anemia requiring rapid correction 5
- Don't continue oral iron indefinitely if ineffective: Switch to IV iron after a failed trial rather than persisting with oral therapy 1
- Don't forget to treat the underlying cause: Iron replacement alone is insufficient if ongoing blood loss continues untreated 6